Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04804072 · ClinicalTrials.gov registry record · NA
INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit
A NA study, sponsored by HIV Prevention Trials Network.
- Completed
- Registry status
- NA
- Development phase
- 447
- Enrollment target
NCT04804072 is a NA study that has completed, run by HIV Prevention Trials Network. The registered enrollment target is 447 participants.
The verdict
NCT04804072, a NA study, has completed, sponsored by HIV Prevention Trials Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 447 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of using a mobile health delivery unit ("mobile unit") to deliver "one stop" integrated health services - particularly medication for opioid use disorder (MOUD) and medication for HIV treatment and prevention - to people who inject drugs (PWID) with opioid use disorder (OUD) to improve uptake and use of MOUD, and uptake and use of antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP).
Interventions
- DRUG Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)
- DIAGNOSTIC_TEST HIV testing
- DRUG HIV treatment for participants living with HIV not already in care
- DRUG PrEP for participants without HIV
- DIAGNOSTIC_TEST Testing and referral for vaccination or treatment for hepatitis A virus (HAV) and hepatitis B virus (HBV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2021-06-02 |
| Est. Completion | 2024-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04804072
The ClinicalTrials.gov registry entry for NCT04804072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HIV Prevention Trials Network, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD) is the first listed.
NCT04804072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04804072 about?
NCT04804072 is a clinical study titled "INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit". The purpose of this study is to determine the efficacy of using a mobile health delivery unit ("mobile unit") to deliver "one stop" integrated health services - particularly medication for opioid use disorder (MOUD) and medication for HIV treatment and prevention - to people who inject drugs (PWID) ...
What is the current status of trial NCT04804072?
This trial is currently completed. It is a NA study. The enrollment target is 447 participants. The study started on 2021-06-02. Estimated completion is 2024-12-17.
What interventions are being tested in trial NCT04804072?
The interventions under investigation include: Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD) (DRUG), HIV testing (DIAGNOSTIC_TEST), HIV treatment for participants living with HIV not already in care (DRUG), PrEP for participants without HIV (DRUG), Testing and referral for vaccination or treatment for hepatitis A virus (HAV) and hepatitis B virus (HBV) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04804072?
This trial is sponsored by HIV Prevention Trials Network, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.